| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $660.1M | +48.9% |
| Cost of Revenue | $139.3M | +71.1% |
| R&D Expense | $66.6M | +86.7% |
| SG&A Expense | $143.5M | +185.2% |
| Operating Income | $267.5M | -3.0% |
| Interest Expense | $16.9M | +125.2% |
| Pre-tax Income | $248.9M | +0.2% |
| Income Tax | $46.8M | +130.3% |
| Net Income | $202.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $234.2M | +97.3% |
| Accounts Receivable | $231.1M | +154.0% |
| Inventory | $100.1M | +85.7% |
| Current Assets | $739.0M | -20.2% |
| Total Assets | $1.84B | +66.7% |
| Current Liabilities | $130.8M | +11.6% |
| Long-term Debt | $1.49B | +89.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $240.1M | -19.8% |
| Capital Expenditures | $4.8M | +230.1% |
| Investing Cash Flow | -$487.0M | -19.9% |
| Financing Cash Flow | $362.4M | +365.4% |
| Free Cash Flow | $235.3M | -21.0% |
| -49.8% |
| EPS (Basic) | $1.48 | -48.3% |
| EPS (Diluted) | $1.44 | -47.4% |
| Stockholders' Equity |
| $169.8M |
| -13.8% |